Patent · US Active

Peptide compositions

US10858399B2 · kind B2 · utility

1Cited by

9References

20Claims

0Family size

Assignee

RHYTHM PHARMACEUTICALS, INC. · US

Inventors

Shubh D. Sharma · Cranbury, US
Leonardus H. T. Van Der Ploeg · Newton, US
Bart Henderson · Belmont, US

Key dates

Filing date	Dec 11, 2018
Grant date	Dec 8, 2020
Priority date	—
Expiry date	Dec 11, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to polypeptide compounds that are modulators (e.g., agonists and antagonists) of the melanocortin-4 receptor (MC4R) and pharmaceutical compositions comprising same. The compounds described herein are polypeptide of the following structural Formula (I): or a pharmaceutically acceptable salt thereof. Values and preferred values of the variables in structural Formula (I) are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.